On Demand Webcast:
Date Recorded: Thursday, March 14th, 2013
TIBCO Spotfire - Complimentary On Demand Webcast
Given the multitude of medications that have lost or are soon to lose patent protection, sales from new medications cannot replace the lost sales. In the next 5 years, two-thirds of pharmaceutical sales growth will come from emerging markets. This represents roughly $150 billion in new revenue and will raise the share of pharmaceutical sales in emerging markets to almost 30 percent of the global pharmaceutical market.
In Part I of our Winning in Emerging Markets with TIBCO Spotfire series, we will discuss how Life Science companies can leverage visualization-based data discovery to build market dynamic and demographic profiles by integrating data from various operational and marketing applications, syndicated and other data sources to identify target countries, segments and channels.
We will discuss how dimension-free data exploration can be performed by periods, products, packaging, countries and sub-markets while factoring in reimbursement: private out-of-pocket, social insurance, publicly subsidized programs. This allows commercial teams to quickly identify highest potential markets, identify their competitors and customize a diverse, multichannel product portfolio for local health demographics and medical practice.
Also covered will be how local teams can be equipped with self-service discovery methods that empower them with analytics such as: pharmacoeconomic, comparator effectiveness, observational research, product quality and authenticity to sell into resistant markets with local competitors and provide analytical data to negotiate with governments that are trying to curb drug prices and promote the interests of local generics companies.
Questions? Please email the Spotfire Team